• Profile
Close

Changes in biomarker profile and left ventricular hypertrophy regression: Results from the Frequent Hemodialysis Network Trials

American Journal of Nephrology Apr 11, 2018

Chan CT, et al. - In this post hoc observational cohort study, researchers ascertained pathways related to regression of left ventricular mass (LVM) in patients enrolled in the Frequent HD Network (FHN) trials, presuming that left ventricular hypertrophy (LVH) regression with frequent hemodialysis (HD) was associated with a different cardiovascular biomarker profile. Patients who achieved a reduction of more than 10% in LVM at 12 months were named as regressors and progressors were those who had a minimum of 10% increase in LVM at 12 months. Mean LVM change differed between regressors and progressors by –65.6g. In the dialysis population, the potential novel pathways that were found to be related to regression of LVH were markers of collagen turnover and changes in klotho levels.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay